A first in man study of PAS-Coversin

Trial Profile

A first in man study of PAS-Coversin

Phase of Trial: Phase I

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Coversin (Primary)
  • Indications Haemolytic uraemic syndrome; Paroxysmal nocturnal haemoglobinuria; Sjogren's syndrome
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 21 Dec 2016 According to an Akari Therapeutics media release, the company expects to initiate first in man trials in the fourth quarter of 2017.
    • 21 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top